Document Detail

High concentration of deoxycholic acid abrogates in vitro transformation of IEC6 intestinal cells by azoxymethane.
MedLine Citation:
PMID:  16471326     Owner:  NLM     Status:  MEDLINE    
In this study, we designed an in vitro azoxymethane (AOM)-induced carcinogenesis model and analyzed the effect of deoxycholic acid (DCA) on growth, apoptosis, genotoxicity, and transformation of IEC6 intestinal cells. CYP2E1 production was confirmed in IEC6 cells. The growth of IEC6 cells was enhanced by DCA (100 microg/ml). However, IEC6 cells treated with DCA (200 microg/ml) were inhibited and disappeared at 48 hrs after treatment. Apoptotic cells increased 11.2 times by treatment with DCA (200 microg/ml) as compared to cells with no treatment. DNA injury detected by comet assay was found in cells treated with AOM, but not in cells treated with DCA (100 microg/ml) and AOM. The number of colony formation in soft agar increased by AOM treatment. However, the number of foci treated with DCA (100 microg/ml) plus AOM was 69% that of cells treated with AOM alone. Two out of the 6 mice subcutaneously injected with AOM-treated IEC6 cells showed tumorigenesis, whereas IEC6 cells treated with DCA (100 microg/ml) plus AOM or DCA (100 microg/ml) alone did not form any tumor. Reduced protein expression of MLH1, Bcl-2 was detected in IEC6 cells treated with DCA (100 microg/ml). Production of Bax, pJNK, TGF-beta, TGFBRI, TGFBRII, and beta-catenin were higher in IEC6 cells treated with DCA (100 microg/ml) than that in cells with no treatment. These results suggest that high-dose DCA induced apoptosis and inhibited AOM-induced in vitro transformation of IEC6 cells.
T Sasaki; H Shimura; T Sasahira; K Fujii; H Kuniyasu
Related Documents :
2251246 - Transmission electron microscopic studies on the effects of toltrazuril on glugea anoma...
21592566 - The influence of elastin-like recombinant polymer on the self-renewing potential of a 3...
3484646 - Identification of leukemia cell-derived inhibitory activity (lia) in conditioned media ...
10898866 - Phosphate feeding improves high-cell-concentration ns0 myeloma culture performance for ...
2481936 - Epithelial differentiation in synovial sarcoma. correlation with histology and immunoph...
20336056 - Adipose tissue explants and mdck cells reciprocally regulate their morphogenesis in coc...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of experimental & clinical cancer research : CR     Volume:  24     ISSN:  0392-9078     ISO Abbreviation:  J. Exp. Clin. Cancer Res.     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2006-02-13     Completed Date:  2006-06-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8308647     Medline TA:  J Exp Clin Cancer Res     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  625-31     Citation Subset:  IM    
Dept. of Molecular Pathology, Nara Medical University, Nara, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / pharmacology*
Apoptosis / drug effects
Azoxymethane / toxicity
Carcinogens / toxicity
Cell Line
Cell Proliferation / drug effects
Cell Transformation, Neoplastic / chemically induced,  drug effects*
Comet Assay
Cytochrome P-450 CYP2E1
Deoxycholic Acid / pharmacology*
Mice, Nude
Neoplasms, Experimental / drug therapy*
Reg. No./Substance:
0/Antineoplastic Agents; 0/Carcinogens; 25843-45-2/Azoxymethane; 83-44-3/Deoxycholic Acid; EC P-450 CYP2E1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of incadronate on proliferation of mesenchymal tumor cells with or without activated Ras muta...
Next Document:  C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.